Vall d'Hebron University Hospital in Spain said it completed Europes first single-port robotic pediatric nephroureterectomy in late June 2026, using core equipment supplied by Chinese surgical robotics company Surui Robot, according to 36Kr. The hospital said this was its first direct-purchase procurement of Chinese medical devices, and it expects the deployment to add 200 to 300 minimally invasive robotic surgeries per year.
Catalonia Trade & Investment said the region has 1,523 life-sciences companies, with employment equal to 7.3% of the local population and a 4.1% GDP contribution; it also accounts for 46% of Spains pharmaceutical exports. The agency said foreign direct investment in the local health sector totaled EUR 2.28 billion in 2020-2024, spanning 46 projects and creating 6,050 jobs.
Separately, dermatology drugmaker Almirall (ALM) opened a Shanghai office in March 2026 and cited prior deals with Simcere Pharmaceutical (02096.HK) with milestone payments up to $492 million and with Huahai Pharmaceutical (600521) unit Huaotai with total payments up to $340 million.
Vall d'Hebron Hospital Completes Europe First Single-Port Robotic Pediatric Nephroureterectomy Using China-Made Surgical Robot
2026-07-04 18:21:56
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Brazil’s Durigan Says Credit Lines Won’t Affect Monetary PolicyNext article：
巴西杜里甘：信贷措施不影响货币政策
